Friday, January 19, 2018 3:16:46 PM
Momenta Pharmaceuticals Inc. is exploring
strategic options ranging from partnerships to selling all or
part of the U.S. drugmaker, people familiar with the matter
said.
Momenta is working with a financial adviser to evaluate
alternatives, the people said, asking not to be identified
because the discussions are private. While deliberations are at
an early stage and the firm may decide against any transaction,
the company could attract interest from larger drugmakers, the
people said. The stock jumped.
SANUWAVE Announces Record Quarterly Revenues: Q3 FY2024 Financial Results • SNWV • Nov 8, 2024 7:07 AM
DBG Pays Off $1.3 Million in Convertible Notes, which Retires All of the Company's Convertible Notes • DBGI • Nov 7, 2024 2:16 PM
SMX and FinGo Enter Into Collaboration Mandate to Develop a Joint 'Physical to Digital' Platform Service • SMX • Nov 7, 2024 8:48 AM
Rainmaker Worldwide Inc. (OTC: RAKR) Announces Successful Implementation of 1.6 Million Liter Per Day Wastewater Treatment Project in Iraq • RAKR • Nov 7, 2024 8:30 AM
SBC Medical Group Holdings and MEDIROM Healthcare Technologies Announce Business Alliance • SBC • Nov 7, 2024 7:00 AM
VAYK Confirms Insider Buying at Open Market • VAYK • Nov 5, 2024 10:40 AM